Blood Pressure Regulation in Pheochromocytoma

Two sets of studies were performed in 13 patients with prored adrenal pheochromocytoma to test the hypothesis that the sympathetic nervous system (SNS) Is active and might contribute to the hypertensire state. Similar studies were performed in 15 additional patients considered to have essential hypertension. In the first set, 13 patients with pheochromocytoma were subjected to head-up tilt to assess the activity of the SNS. This maneuver decreased diastolic blood pressure in only two; heart rate increased appropriately in all except one. Changes in plasma noreplnephrine (NE) were variable and did not correlate with changes in blood pressure (BP) and heart rate (HR).In the second set, 10 patients with pheochromocytoma were given a single oral dose of clonldine (03 mg) to evaluate what role, if any, the SNS might contribute to the hypertensive state. Fifteen patients with essential hypertension were studied similarly for comparison. Clonidlne produced significant decreases in BP and HR but left plasma renln activity unchanged in both groups. In essential hypertension, the cardiovascular responses were accompanied by significant reductions in plasma NE. By contrast, plasma NE was unchanged in patients with pheochromocytoma, despite similar reductions in BP and HR. These results suggest that the sympathetic reflexes are intact in pbeochromocytoma, and that much of the hypertension associated with these tumors may be related to increased sympathetic activity. (Hypertension 4 (suppl II): II-193-II-199, 1982)

[1]  R. Tarazi,et al.  Long‐Term Converting Enzyme Inhibition and Sympathetic Nerve Function in Hypertensive Humans , 1981, Hypertension.

[2]  D. Adams,et al.  Essential Hypertension: Abnormal Renal Vascular and Endocrine Responses to a Mild Psychological Stimulus , 1981, Hypertension.

[3]  J. Halter,et al.  Effects of clonidine on hormone and substrate responses to hypoglycemia , 1980, Clinical pharmacology and therapeutics.

[4]  N. Vlachakis,et al.  Catecholamines in pheochromocytoma. , 1980, The New England journal of medicine.

[5]  R W Gifford,et al.  Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. , 1979, The New England journal of medicine.

[6]  H. Dengler,et al.  Evidence for extratumoural storage of catecholamines in pheochromocytoma patients. , 1978, Acta endocrinologica.

[7]  I. Reid,et al.  Mechanism of Suppression of Renin Secretion by Clonidine in the Dog , 1978, Circulation research.

[8]  W. Kobinger Central α-adrenergic systems as targets for hypotensive drugs , 1978 .

[9]  Kobinger Central alpha-adrenergic systems as targets for hypotensive drugs. , 1978, Reviews of physiology, biochemistry and pharmacology.

[10]  J. Halter,et al.  Suppression of plasma catecholamines and flushing by clonidine in man. , 1978, The Journal of clinical endocrinology and metabolism.

[11]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.

[12]  C. Dollery,et al.  Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. , 1977, Clinical science and molecular medicine.

[13]  C. Mathias,et al.  The central hypotensive effect of clonidine; Studies in tetraplegie subjcets , 1977, Clinical pharmacology and therapeutics.

[14]  R. Tarazi,et al.  Dissociation Between Renin and Arterial Pressure Responses to Beta‐Adrenergic Blockade in Human Essential Hypertension , 1975, Circulation research.

[15]  G. Haeusler Cardiovascular Regulation by Central Adrenergic Mechanisms and Its Alteration by Hypotensive Drugs , 1975, Circulation research.

[16]  W. Ganong,et al.  Studies concerning the mechanism of suppression of renin secretion by clonidine. , 1975, The Journal of pharmacology and experimental therapeutics.

[17]  R. Tarazi,et al.  β-Adrenergic Blockade in Diuretic-Treated Patients with Essential Hypertension , 1975 .

[18]  R. Tarazi,et al.  On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol. , 1974, The Journal of laboratory and clinical medicine.

[19]  A. D. Smith,et al.  Phaeochromocytoma and Other Catecholamine-Producing Tumours , 1972 .

[20]  J. Laragh,et al.  Suppression of Renin and Aldosterone by Clonidine. , 1971 .

[21]  A. Schwartz,et al.  Antihypertensive Effect of Clonidine , 1971, Circulation research.

[22]  H. Hedeland,et al.  Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients. , 1970, European journal of pharmacology.

[23]  A. D. Smith,et al.  Catecholamines in phaeochromocytoma. Normal storage but abnormal release? , 1968, Lancet.

[24]  A. Sjoerdsma,et al.  A NEW TEST FOR PHEOCHROMOCYTOMA. PRESSOR RESPONSIVENESS TO TYRAMINE. , 1964, JAMA.